David C. Myles, CH. DISCOV. & NON-CLIN Development Officer at Olema Pharmaceuticals, Inc. (OLMA), sold 51,832 shares at $8.66 ($467K) on 2024-12-11, disclosed to the SEC on 2024-12-11.
Open-market sale of $467k OLMA by CH. DISCOV. & NON-CLIN Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.38 | 12,452 | $117K | 25.0% |
| 2 | $9.38 | 12,452 | $117K | 25.0% |
| 3 | $8.66 | 13,314 | $115K | 24.7% |
| 4 | $8.66 | 13,314 | $115K | 24.7% |
| 5 | $9.39 | 300 | $3K | 0.6% |
| Total | $9.01 avg | 51,832 |
| $467K |
| 100% |
| Filing → |
| OLMA | SELL | 2023-11-22 | $389K | — | Filing → |
| OLMA | SELL | 2023-11-13 | $4K | — | Filing → |
| OLMA | SELL | 2023-11-03 | $312K | — | Filing → |